STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN

Detalles Bibliográficos
Main Authors:	Walton, R, Russell, R, Alberti, K, Clark, M, Potts, J, Bisaz, S, Fleisch, H
Formato:	Journal article
Idioma:	English
Publicado:	1974

Títulos similares

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
por: Walton, R, et al.
Publicado: (1974)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
por: Walton, R, et al.
Publicado: (1975)

Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
por: Walton, R, et al.
Publicado: (1976)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
por: Russell, R, et al.
Publicado: (1979)

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
por: Smith, R, et al.
Publicado: (1973)

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
por: Russell, R, et al.
Publicado: (1975)

ABNORMAL RESPONSES TO EHDP TREATMENT OF PAGETS-DISEASE
por: Smith, R, et al.
Publicado: (1977)

Diphosphonates in Paget's disease.
por: Russell, R, et al.
Publicado: (1974)

Diphosphonates and polyphosphates in medicine
por: Russell, R
Publicado: (1975)

Synthesis of Four Enantiomers of (1-Amino-3-Hydroxypropane-1,3-Diyl)Diphosphonic Acid as Diphosphonate Analogues of 4-Hydroxyglutamic Acid
por: Liwia Lebelt, et al.
Publicado: (2022-04-01)

Microstructure and Phase Characterization of Alkali-Activated Slag–Fly Ash Materials with Tetrasodium of 1-Hydroxy Ethylidene-1, 1-Diphosphonic Acid (HEDP·4Na)
por: Bo Zhou, et al.
Publicado: (2024-05-01)

Treatment of myositis ossificans progressiva with a diphosphonate.
por: Russell, R, et al.
Publicado: (1972)

Complexation of 1-Hydroxyethylidene-1,1-Diphosphonic Acid (HEDP) and Manganese(II) in Aqueous Solution
por: О.V. Bogatyrev, et al.
Publicado: (2016-03-01)

Proceedings: Background to the use of diphosphonates as bone scanning agents.
por: Russell, R, et al.
Publicado: (1975)

Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
por: Gray, R, et al.
Publicado: (1987)

Treatment of [99mTc]Tc‐hydroxy‐diphosphonate ([99mTc]Tc‐HDP) extravasation using hyaluronidase
por: Kevin R. Doornhof, et al.
Publicado: (2024-08-01)

The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats
por: Russell, R, et al.
Publicado: (1970)

Diaquabis{[1-hydroxy-2-(1H-imidazol-3-ium-1-yl)ethane-1,1-diyl]bis(hydrogen phosphonato)}manganese(II)
por: Yu Zhang, et al.
Publicado: (2009-12-01)

1-(5-Hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethan-1-one
por: Bingjing Liu, et al.
Publicado: (2010-06-01)

catena-Poly[zinc(II)-&#956;3-{hydrogen [1-hydroxy-2-(3-pyridinio)ethane-1,1-diyl]diphosphonato}]
por: Xihe Huang, et al.
Publicado: (2010-01-01)

Impact and mechanism of bisphosphonate depressant 1-hydroxypropane-1,1-diphosphonic acid on flotation decalcification of dolomite-rich magnesite ore
por: Wengang Liu, et al.
Publicado: (2024-07-01)

1-Phenyl-1-[(1-phenylethyl)sulfonylmethylsulfonyl]ethane
por: Jing-tao Liu, et al.
Publicado: (2009-12-01)

Hyperphosphatemia and Cardiovascular Disease
por: Chao Zhou, et al.
Publicado: (2021-03-01)

Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1
por: Hualong Zang, et al.
Publicado: (2024-01-01)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
por: Ju-Young Moon, et al.
Publicado: (2015-03-01)

Synthesis and structure of heterometallic multiligand Ge(IV) - 3d-metals complexes with 1-hydroxyethane-1,1-diphosphonic acid and 1,10-phenanthroline
por: Kyrylo Tsymbaliuk, et al.
Publicado: (2024-12-01)

Crystal structure of 1-(6-hydroxy-2-phenylbenzofuran-5-yl)ethan-1-one, C16H12O3
por: Olomola Temitope O., et al.
Publicado: (2020-10-01)

1-(Pyrrolidin-1-yl)ethan-1-iminium chloride
por: Rylan Artis, et al.
Publicado: (2023-09-01)

Disodium 4,5,6-trihydroxybenzene-1,3-disulfonate dihydrate
por: U. Beginn, et al.
Publicado: (2010-10-01)

Crystal structure of 1-(4-chloro-2-hydroxy-5-iodophenyl)ethan-1-one, C8H6ClIO2
por: Mphahlele Malose J.
Publicado: (2019-12-01)

Crystal structure of (E)-1-(2-hydroxy-3-{[2-hydroxybenzylidene]amino}phenyl)ethan-1-one, C15H13NO3
por: Yang Yu-Hua, et al.
Publicado: (2017-11-01)

Clinical Characteristics and Outcomes of Hyperphosphatemia in Patients with Chronic Kidney Disease Stages 1–2
por: Chao Xie, et al.
Publicado: (2024-07-01)

Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy
por: Walton, K, et al.
Publicado: (1985)

Hyperphosphatemia in chronic kidney disease
por: S. A. Martynov, et al.
Publicado: (2019-10-01)

Optimizing 1-hydroxyethylidene-1,1-diphosphonic acid and mechanically-activated iron ore tailings to prepare low-cost and retarded magnesium oxysulfate cement
por: Huihui Liang, et al.
Publicado: (2022-12-01)

New amino bisphosphonate compound for skeletal imaging: Comparison study with methylenediphosphonic acid (MDP) and (1-hydroxyethane-1,1-diyl) diphosphonic acid (HEDP)
por: Assaad Thaer
Publicado: (2016-03-01)

3,3′-[(1E,1′E)-Hydrazine-1,2-diylidenebis(ethan-1-yl-1-ylidene)]bis(4-hydroxy-6-methyl-2H-pyran-2-one)
por: Abouelhaoul El Alami, et al.
Publicado: (2019-10-01)

(E)-1-(4-Bromophenyl)ethan-1-one semicarbazone
por: Hoong-Kun Fun, et al.
Publicado: (2009-07-01)

(E)-1-(4-Fluorophenyl)ethan-1-one semicarbazone
por: Hoong-Kun Fun, et al.
Publicado: (2009-07-01)

Preparation of anti-reversion agent disodium hexamethylene-1,6-dithiosulfate dihydrate
por: LI Tian-yu1, HOU Wen-jie2, SHI Yun-hai1, YU Tao1
Publicado: (2024-01-01)